Biopsy, Salivary Gland
Glutamic Acid Decarboxylase (GAD65) Antibody, CSF
Methylmalonic Acid (MMA), Quantitative, Urine
Brucella Nucleic Acid Detection by PCR
Gardnerella vaginalis
Lactate, CSF
Circulating Tumor Cells (CTC), Prostate Cancer
Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis
Dilute Russell Viper Venom Time (dRVVT)
Thrombopoietin
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Additional ICD10
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now